RSEGX
Price
$57.56
Change
-$0.53 (-0.91%)
Updated
Oct 7 closing price
Net Assets
399.67M
VSGAX
Price
$105.96
Change
-$1.18 (-1.10%)
Updated
Oct 7 closing price
Net Assets
39.1B
Interact to see
Advertisement

RSEGX vs VSGAX

Header iconRSEGX vs VSGAX Comparison
Open Charts RSEGX vs VSGAXBanner chart's image
Victory RS Small Cap Growth A
Price$57.56
Change-$0.53 (-0.91%)
VolumeN/A
Net Assets399.67M
Vanguard Small Cap Growth Index Admiral
Price$105.96
Change-$1.18 (-1.10%)
VolumeN/A
Net Assets39.1B
RSEGX vs VSGAX Comparison Chart in %
View a ticker or compare two or three
VS
RSEGX vs. VSGAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSEGX is a Hold and VSGAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGAX has more cash in the bank: 39.1B vs. RSEGX (400M). VSGAX pays higher dividends than RSEGX: VSGAX (0.56) vs RSEGX (0.00). RSEGX was incepted earlier than VSGAX: RSEGX (38 years) vs VSGAX (14 years). RSEGX (1.41) is less costly to investors than VSGAX (0.07). RSEGX is a more actively managed with annual turnover of: 120.00 vs. VSGAX (21.00). RSEGX has a lower initial minimum investment than VSGAX: RSEGX (2500) vs VSGAX (3000). VSGAX annual gain was more profitable for investors over the last year : 15.06 vs. RSEGX (1.63). VSGAX return over 5 years is better than : 34.51 vs. RSEGX (-36.82).
RSEGXVSGAXRSEGX / VSGAX
Total Expense Ratio1.400.072,000%
Annual Report Gross Expense Ratio1.410.072,014%
Fund Existence38 years14 years-
Gain YTD-0.2928.954-3%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets400M39.1B1%
Annual Yield % from dividends0.000.56-
Returns for 1 year1.6315.0611%
Returns for 3 years23.2853.6843%
Returns for 5 years-36.8234.51-107%
Returns for 10 years-12.55150.38-8%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIEIX34.86N/A
N/A
Principal Glb Emerging Markets Inst
ETIHX42.42N/A
N/A
Eventide Healthcare & Life Sciences I
ENHNX10.33N/A
N/A
Cullen Enhanced Equity Income I
LICOX18.69N/A
N/A
Lord Abbett International Equity F3
RGABX78.57-0.51
-0.64%
American Funds Growth Fund of Amer R2